As part of our strategy to streamline our corporate structure and internal procedures, the management has decided to merge the activities of NUKEM Isotopes Imaging GmbH with those of NUKEM Isotopes GmbH. On this occasion, the company was merged with retroactive effect to 01.01.2019 on the NUKEM Isotopes GmbH. This step has already been certified by the notary and will be registered with the commercial register in a timely manner. We are confident that this step will further improve the service to our customers and suppliers and will contribute to more efficient fulfillment of the needs of our client orders. As a result of this operational change, customer orders for isotopes which find their application in medical technology, e.g. Oxygen-17 or Xenon-129 are again accepted directly by NUKEM Isotopes GmbH.
If you need more information on this topic, please do not hesitate to contact us anytime at firstname.lastname@example.org. Of course you are also welcome to contact your direct contacts.